CAG
Valuation isn’t giving you much of a discount
BTIG just started covering Conagra Brands (CAG) with a Neutral rating, and the message is pretty blunt: the stock may look sleepy-cheap, but it’s not exactly the kind of sleepy-cheap that screams “run, don’t walk.” The firm pointed out that Conagra is trading around 9x fiscal 2027 EPS, which is below its own history — about a 10% discount to the last 12 months average and roughly 30% below its 10-year average.
Cheap for a reason?
Conagra shares were sitting near $14.51, not far from the 52-week low of $15.04. That’s the market basically saying, “Sure, maybe this is value… but let’s not get ahead of ourselves.” When a packaged-food name trades like it’s been left on the back shelf, investors usually want one of two things: a growth story or a margin comeback. Right now, BTIG seems to think Conagra has neither in convincing enough size.
Why you should care
This matters because Conagra has already been living through the messy part of the grocery aisle: weaker margins, a softer earnings setup, and a stock that’s been more “defensive hiding place” than “must-own winner.” A Neutral call doesn’t change the thesis dramatically, but it does reinforce the idea that the market is waiting for clearer proof before giving the company a fancier multiple.
The bigger picture
Analyst ratings don’t move the whole story by themselves, but they help frame the debate. In Conagra’s case, the debate is whether the shares are genuinely undervalued or just accurately priced for a business that’s still trying to get its groove back.
Big picture: when a stock is cheap and nobody’s rushing in anyway, that usually means the burden of proof is still on management, not the market.